Non-defective Epstein-Barr viral vector
US6544781B1 · kind B1 · utility
1Cited by
7References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2000 |
| Grant date | Apr 8, 2003 |
| Priority date | — |
| Expiry date | Jul 17, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16243
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a viral vector system derived from Epstein-Barr Virus (EBV), where the transgene is effectively inserted into the EBV major internal repeat region (IR1) without adverse affect on EBV latent or lytic function. The vector of the invention can target and stably transform B-lymphocyte cells, both in culture and in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.